Asylia Therapeutics
PrivateLast Round
Grant
Aug 17, 2022
Total Funding Raised
$20.75M
Company Overview
Asylia Therapeutics operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Grant round in August 2022.
Asylia Therapeutics is a biotechnology company that develops novel immune-modulating therapies for the treatment of cancer, autoimmune, and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asylia Therapeutics Comparables
Compare Asylia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leukogene Therapeutics | 77% | |
| GV20 Therapeutics | 77% | |
| Corner Therapeutics | 75% |
For institutional investors. Book with your work email.
Asylia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 17, 2022 | ||||
| Series A | May 25, 2021 | ||||
| Grant | Feb 19, 2020 |
For institutional investors. Book with your work email.
Asylia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 76% MoM.
- May 25, 2021
$15M round led by Sporos Bioventures
For institutional investors. Book with your work email.
Asylia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Asylia Therapeutics's valuation, stock price, and market status.
Is Asylia Therapeutics a public or private company?
Asylia Therapeutics is a private company.
What is the current stock price of Asylia Therapeutics?
Asylia Therapeutics is a private company, so its shares have no public market price. Caplight tracks Asylia Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Asylia Therapeutics worth (valuation)?
Valuation information for Asylia Therapeutics is not publicly available.
Can I buy Asylia Therapeutics stock?
Asylia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Asylia Therapeutics's last funding round?
Asylia Therapeutics's most recent funding round was Grant on August 17, 2022.
Who are the main investors in Asylia Therapeutics?
Key investors in Asylia Therapeutics include National Institutes of Health (NIH), Cancer Prevention and Research Institute of Texas.
Will Asylia Therapeutics IPO soon?
No public IPO plans have been announced for Asylia Therapeutics.
How can I track Asylia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Asylia Therapeutics's shares on secondary markets.